Home / Stocks / RANI

RANI insider trading

Rani Therapeutics Holdings, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
5
Bought · 24 mo
$1.4M
Buys · last 90 days
2 · $50k
Most recent buy
2026-07-23

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-07-23IMRAN MIR A
Director · 10% owner
Bought36,000$0.69$25k
2026-07-21Imran Talat
Chief Executive Officer
Bought35,000$0.72$25k
2025-10-27IMRAN MIR A
Director · 10% owner
Bought2,083,334$0.61$1.3M
2025-10-22South Cone Investments Limited Partnership
10% owner
Sold5,923,000$2.65$15.7M
2024-12-16McKinley Kate
Chief Business Officer
Bought17,960$1.67$30k
2024-12-10Imran Talat
Chief Executive Officer
Bought10,296$1.94$20k
2024-10-17South Cone Investments Limited Partnership
10% owner
Sold3,829,360$2.65$10.1M

Most active insider buyers

InsiderRoleBuysTotal bought
IMRAN MIR ADirector · 10% owner2$1.3M
Imran TalatChief Executive Officer2$45k
McKinley KateChief Business Officer1$30k

See RANI on the chart

Every insider buy and sell for RANI plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.